메뉴 건너뛰기




Volumn 272, Issue 7282, 2004, Pages 61-62

Capacity planning for chemotherapy

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; VINCRISTINE;

EID: 1042303535     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (6)
  • 1
    • 0003423173 scopus 로고
    • A policy framework for commissioning cancer services
    • NHS Executive. London: Department of Health
    • NHS Executive. A policy framework for commissioning cancer services. London: Department of Health; 1995.
    • (1995)
  • 2
    • 1042275162 scopus 로고    scopus 로고
    • NHS Plan. London: Department of Health
    • NHS Plan. London: Department of Health; 1999.
    • (1999)
  • 3
    • 0003616768 scopus 로고    scopus 로고
    • NHS Cancer Plan - A plan for investment, a plan for reform
    • London: Department of Health
    • NHS Cancer Plan - A plan for investment,a plan for reform. London: Department of Health; 1999.
    • (1999)
  • 4
    • 0019134144 scopus 로고
    • A simple work measurement system that can aid in effective production planning
    • Trudeau T. A simple work measurement system that can aid in effective production planning, Hospital Pharmacist 1980;15:229-33.
    • (1980) Hospital Pharmacist , vol.15 , pp. 229-233
    • Trudeau, T.1
  • 5
    • 0021454512 scopus 로고
    • Determining staffing for pharmacy chemotherapy admixture programme
    • Matanin D, Carlson K, Bonace B. Determining staffing for pharmacy chemotherapy admixture programme. Hospital Pharmacist 1984;19:514-8.
    • (1984) Hospital Pharmacist , vol.19 , pp. 514-518
    • Matanin, D.1    Carlson, K.2    Bonace, B.3
  • 6
    • 0037442735 scopus 로고    scopus 로고
    • Development of a capacity planning model for pharmaceutical services to cancer patients
    • Low J, Macintyre J, McIver L, Lannigan N. Development of a capacity planning model for pharmaceutical services to cancer patients. The Pharmaceutical Journal 2003;270:239-40.
    • (2003) The Pharmaceutical Journal , vol.270 , pp. 239-240
    • Low, J.1    Macintyre, J.2    McIver, L.3    Lannigan, N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.